Inventor · disambiguated record
Chandrasekhar V. Miduturu
Also filed as: MIDUTURU CHANDRASEKHAR · MIDUTURU CHANDRASEKHAR V
21 granted patents·6 pending applications·509 citations·filing 2013–2022
96Inventor score
Files withBLUEPRINT MEDICINES CORP20BIFULCO JR NEIL3DIPIETRO LUCIAN V1HARVARD COLLEGE1HODOUS BRIAN L1
Top patents by PatentIndex Score
27 records- 0198US9695165B2Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2015·Granted Jul 4, 2017·40 cites·20 claims
- 0297US10000490B2Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2017·Granted Jun 19, 2018·30 cites·12 claims
- 0397US9884861B2Compositions useful for treating disorders related to kitBLUEPRINT MEDICINES CORP·Filed 2016·Granted Feb 6, 2018·32 cites·7 claims
- 0497US9340514B2Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2015·Granted May 17, 2016·43 cites·11 claims
- 0597US8802697B2Inhibitors of the fibroblast growth factor receptorBIFULCO JR NEIL·Filed 2013·Granted Aug 12, 2014·91 cites·9 claims
- 0696US10196436B2Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2018·Granted Feb 5, 2019·17 cites·1 claims
- 0796US9994552B2Compositions useful for treating disorders related to kitBLUEPRINT MEDICINES CORP·Filed 2016·Granted Jun 12, 2018·31 cites·10 claims
- 0896US9434700B2Inhibitors of the fibroblast growth factor receptorBIFULCO JR NEIL·Filed 2014·Granted Sep 6, 2016·45 cites·4 claims
- 0996US9126951B2Inhibitors of the fibroblast growth factor receptorBIFULCO JR NEIL·Filed 2014·Granted Sep 8, 2015·47 cites·41 claims
- 1095US10017512B2Compounds and compositions useful for treating disorders related to NTRKBLUEPRINT MEDICINES CORP·Filed 2016·Granted Jul 10, 2018·29 cites·26 claims
- 1195US9334263B2Compositions useful for treating disorders related to kitHODOUS BRIAN L·Filed 2014·Granted May 10, 2016·41 cites·21 claims
- 1294US11534441B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2021·Granted Dec 27, 2022·3 cites·25 claims
- 1393US10221154B2Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2016·Granted Mar 5, 2019·11 cites·10 claims
- 1493US9499522B2Compositions useful for treating disorders related to kitDIPIETRO LUCIAN V·Filed 2014·Granted Nov 22, 2016·40 cites·27 claims
- 1590US12042495B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Jul 23, 2024·1 cites·18 claims
- 1690US11046697B2Compounds and compositions useful for treating disorders related to NTRKBLUEPRINT MEDICINES CORP·Filed 2018·Granted Jun 29, 2021·5 cites·20 claims
- 1783US10875837B2Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2019·Granted Dec 29, 2020·1 cites·6 claims
- 1873US10370379B2Compounds and compositions useful for treating disorders related to NTRKBLUEPRINT MEDICINES CORP·Filed 2016·Granted Aug 6, 2019·1 cites·12 claims
- 1971US2021347756A1Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2020·Application pending·0 cites
- 2069US10150742B2Substituted heterocyclic compounds for treating or preventing viral infectionsHARVARD COLLEGE·Filed 2014·Granted Dec 11, 2018·1 cites·9 claims
- 2166US2019359682A1Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2018·Application pending·0 cites
- 2261US12202844B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Jan 21, 2025·0 cites·30 claims
- 2360US2024336630A1Map4k1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 2459US2024199648A1Map4k1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 2558US2017066812A1Inhibitors of the fibroblast growth factor receptorBLUEPRINT MEDICINES CORP·Filed 2016·Application pending·0 cites
- 2655US11059827B2Compounds and compositions useful for treating disorders related to NTRKBLUEPRINT MEDICINES CORP·Filed 2019·Granted Jul 13, 2021·0 cites·19 claims
- 2747US2014187559A1Inhibitors of the fibroblast growth factor receptorMIDUTURU CHANDRASEKHAR V·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →